Skip to main content
Top
Published in: Archives of Osteoporosis 1/2022

Open Access 01-12-2022 | Surgery | Original Article

Medical management patterns in a US commercial claims database following a nontraumatic fracture in postmenopausal women

Authors: Xin Wang, Xiaoqing Xu, Mary Oates, Timothy Hill, Rolin L. Wade

Published in: Archives of Osteoporosis | Issue 1/2022

Login to get access

Abstract

Summary

Among women ≥ 50 years with fracture, 76% had not received osteoporosis diagnosis or treatment at 6 months and only 14% underwent a DXA scan. Nearly half of all and 90% of hip fracture patients required surgery. Fractures cause substantial clinical burden and are not linked to osteoporosis diagnosis or treatment.

Purpose

Osteoporosis (OP) and OP-related fractures are a major public health concern, associated with significant economic burden. This study describes management patterns following a nontraumatic fracture for commercially insured patients.

Methods

This retrospective cohort study identified women aged ≥ 50 years having their first nontraumatic index fracture (IF) between January 1, 2015 and June 30, 2019, from IQVIA’s PharMetrics® Plus claims database. Medical management patterns at month 6 and medication use patterns at months 6, 12, and 24 following the IF were described.

Results

Among 48,939 women (mean (SD) age: 62.7 (9.5) years), the most common fracture types were vertebral (30.6%), radius/ulna (24.9%), and hip (HF; 12.1%). By month 6, 76% of patients had not received an OP diagnosis or treatment, 13.6% underwent a DXA scan, and 11.2% received any OP treatment. Surgery was required in 43.1% of all patients and 90.0% of HF patients on or within 6 months of the fracture date. Among HF patients, 41.4% were admitted to a skilled nursing facility, 96.7% were hospitalized an average of 5.5 days, and 38.1% required durable medical equipment use. The 30-day all-cause readmission rate was 14.3% among those hospitalized for the IF. Overall, 7.4%, 9.9%, and 13.2% had a subsequent fracture at months 6, 12, and 24, respectively.

Conclusion

Our findings provide an overview of post-fracture management patterns using real-world data. OP was remarkably underdiagnosed and undertreated following the initial fracture. Nontraumatic fracture, particularly HF, resulted in substantial ongoing clinical burden.
Appendix
Available only for authorised users
Literature
3.
go back to reference Hansen D, Bazell C, Pelizzari P, Pyenson B (2019) Milliman research report: medicare cost of osteoporotic fractures. The clinical and cost burden of an important consequence of osteoporosis. National Osteoporosis Foundation Hansen D, Bazell C, Pelizzari P, Pyenson B (2019) Milliman research report: medicare cost of osteoporotic fractures. The clinical and cost burden of an important consequence of osteoporosis. National Osteoporosis Foundation
8.
go back to reference Pietri M, Lucarini S (2007) The orthopaedic treatment of fragility fractures. Clin Cases Miner Bone Metab 4(2):108–116PubMedPubMedCentral Pietri M, Lucarini S (2007) The orthopaedic treatment of fragility fractures. Clin Cases Miner Bone Metab 4(2):108–116PubMedPubMedCentral
12.
go back to reference Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1–46. https://doi.org/10.4158/GL-2020-0524SUPPLCrossRefPubMed Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, Harris ST, Hurley DL, Kelly J, Lewiecki EM, Pessah-Pollack R, McClung M, Wimalawansa SJ, Watts NB (2020) American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract 26(Suppl 1):1–46. https://​doi.​org/​10.​4158/​GL-2020-0524SUPPLCrossRefPubMed
13.
go back to reference Khan AZ, Rames RD, Miller AN (2018) Clinical management of osteoporotic fractures. Curr Osteoporos Rep 16(3):299–311CrossRefPubMed Khan AZ, Rames RD, Miller AN (2018) Clinical management of osteoporotic fractures. Curr Osteoporos Rep 16(3):299–311CrossRefPubMed
16.
go back to reference Budhia S, Mikyas Y, Tang M, Badamgarav E (2012) Osteoporotic fractures. Pharmacoeconomics 30(2):147–170CrossRefPubMed Budhia S, Mikyas Y, Tang M, Badamgarav E (2012) Osteoporotic fractures. Pharmacoeconomics 30(2):147–170CrossRefPubMed
17.
go back to reference Becker DJ, Yun H, Kilgore ML et al (2010) Health services utilization after fractures: evidence from Medicare. J Gerontol A Biol Sci Med Sci 65(9):1012–1020CrossRefPubMed Becker DJ, Yun H, Kilgore ML et al (2010) Health services utilization after fractures: evidence from Medicare. J Gerontol A Biol Sci Med Sci 65(9):1012–1020CrossRefPubMed
18.
go back to reference Kumar A, Rahman M, Trivedi AN, Resnik L, Gozalo P, Mor V (2018) Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: a secondary analysis of administrative data. PLoS Med 15(6):e1002592 Kumar A, Rahman M, Trivedi AN, Resnik L, Gozalo P, Mor V (2018) Comparing post-acute rehabilitation use, length of stay, and outcomes experienced by Medicare fee-for-service and Medicare Advantage beneficiaries with hip fracture in the United States: a secondary analysis of administrative data. PLoS Med 15(6):e1002592
19.
go back to reference Liu J, Gong T, Xu X, Fox KM, Oates M, Gandra SR (2022) Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries. Osteoporos Int 33(2):413–423CrossRefPubMed Liu J, Gong T, Xu X, Fox KM, Oates M, Gandra SR (2022) Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries. Osteoporos Int 33(2):413–423CrossRefPubMed
20.
go back to reference Lanteigne A, Sheu YH, Stürmer T, Pate V, Azrael D, Swanson SA, Miller M (2015) Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older CNS drugs 29(3):245–52 Lanteigne A, Sheu YH, Stürmer T, Pate V, Azrael D, Swanson SA, Miller M (2015) Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older CNS drugs 29(3):245–52
21.
go back to reference Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2019) Risk of subsequent fracture after prior fracture among older women. Osteoporos Int 30(1):79–92CrossRefPubMed Balasubramanian A, Zhang J, Chen L, Wenkert D, Daigle SG, Grauer A, Curtis JR (2019) Risk of subsequent fracture after prior fracture among older women. Osteoporos Int 30(1):79–92CrossRefPubMed
22.
go back to reference Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL (2015) DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women. J Clin Densitom 18(2):145–149CrossRefPubMedPubMedCentral Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL (2015) DXA utilization between 2006 and 2012 in commercially insured younger postmenopausal women. J Clin Densitom 18(2):145–149CrossRefPubMedPubMedCentral
23.
go back to reference Weaver J, Sajjan S, Lewiecki EM, Harris ST (2017) Diagnosis and treatment of osteoporosis before and after fracture: a side-by-side analysis of commercially insured and Medicare advantage osteoporosis patients. J Manag Care Spec Pharm 23(7):735–744PubMed Weaver J, Sajjan S, Lewiecki EM, Harris ST (2017) Diagnosis and treatment of osteoporosis before and after fracture: a side-by-side analysis of commercially insured and Medicare advantage osteoporosis patients. J Manag Care Spec Pharm 23(7):735–744PubMed
24.
go back to reference Jakob F, Marin F, Martin-Mola E, Torgerson D, Fardellone P, Adami S, ... & Cooper C (2006) Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). J Assoc Phys 99(8):531-543 Jakob F, Marin F, Martin-Mola E, Torgerson D, Fardellone P, Adami S, ... & Cooper C (2006) Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO). J Assoc Phys 99(8):531-543
Metadata
Title
Medical management patterns in a US commercial claims database following a nontraumatic fracture in postmenopausal women
Authors
Xin Wang
Xiaoqing Xu
Mary Oates
Timothy Hill
Rolin L. Wade
Publication date
01-12-2022
Publisher
Springer London
Published in
Archives of Osteoporosis / Issue 1/2022
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-022-01135-4

Other articles of this Issue 1/2022

Archives of Osteoporosis 1/2022 Go to the issue